National radiology network Radnet to acquire iCAD for over $100 million for its breast cancer screening AI algorithm.

The results of a large survey from a diverse patient population revealed cautious support for artificial intelligence (AI) ...

Los Angeles-based RadNet Inc. announced the proposed acquisition of iCAD Inc. for approximately $100 million on April 15. The transaction is subject to approval by iCAD stockholders and other ...

Burjeel Holdings has entered a partnership with US-based Paige for deploying AI approved by the Food and Drug Administration ...

Unlike traditional CPU or GPU deployments of AI models, which require high computational resources and often suffer from ...

Explore how standalone AI outperforms radiologists in detecting second breast cancers in postmastectomy patients.

Artificial intelligence (AI) can accurately suggest appropriate adjuvant treatment for patients with early breast cancer, according to research published in JCO Clinical Cancer Informatics.

The van offers free cancer check-ups, including thermal screening for breast cancer, pap smear/VIA for cervical cancer, blood ...

This merger aims to enhance RadNet's existing AI-powered cancer detection solutions, particularly in breast cancer screening, by integrating iCAD's technologies and expertise into its subsidiary ...

The initiative aims to provide free and timely breast cancer detection, especially in rural areas and industrial settings. Equipped with Thermalytix, an AI-powered tool, the van offers quick ...

The acquisition will unite complementary leading AI-powered cancer detection and workflow solutions focused on improving the accuracy and early detection of breast cancer The transaction is expect ...

Despite strong performance from AI, fewer recalls from AI-flagged cases point to challenges in human-AI collaborationSEOUL, South Korea, April ...